Allan Jonathan's Form 4 filing
Stoke Therapeutics, Inc. (STOK) · filed Mar 19, 2026
- Accession no.
- 0001966716-26-000006
- Filed
- Mar 19, 2026
- Trade date
- Mar 17-18, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 5 non-derivative transactions. Open-market sales total $285.9K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Allan JonathanCIK 0001966716 | Officer (GENERAL COUNSEL & CORP SEC) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 17, 2026 | Common Stock | SSaleDisposed | −2,476 | $32.74 | −$81,064.24 | 35,255 | Direct | |
| Mar 17, 2026 | Common Stock | SSaleDisposed | −1,791 | $33.38 | −$59,783.58 | 33,464 | Direct | |
| Mar 18, 2026 | Common Stock | SSaleDisposed | −4,222 | $31.28 | −$132,064.16 | 29,242 | Direct | |
| Mar 18, 2026 | Common Stock | SSaleDisposed | −334 | $31.79 | −$10,617.86 | 28,908 | Direct | |
| Mar 18, 2026 | Common Stock | SSaleDisposed | −72 | $32.85 | −$2,365.2 | 28,836 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.